“a favorable trend”

In accordance with the observed improvements in behavioral assessments, electrophysiological evaluations performed at eight weeks post-surgery revealed a favorable trend toward enhanced motor recovery in animals treated with the Exo-dECM hydrogel ( Fig. 4 H and I).

Both when VR training was analyzed and reviewed separately, and when compared to traditional training, the findings exhibited predominantly promising outcomes, reflecting a favorable trend in the study.

Despite observing a favorable trend, such as a 21% reduction in risk, statistical significance was not attained 34 .

[ 6 ] also demonstrates a favorable trend and exhibits much lower error compared to the other two models, yet it still holds an error of 201.83cp.

A high overall score indicates a positive psychosocial status, reflecting a favorable trend in social skills and self-confidence.

Unfortunately, no significant difference ( P = 0.180) was observed between the groups, although the ERBT group exhibited a favorable trend in RFS.

A log-rank test indicated a borderline statistical significance ( p = 0.058) in the survival distributions among the different DDD adherence, with the lower dose group showing a favorable trend.

All diets, except for D2, showed a favorable trend according to the species’ reproductive potential.

The ratios HDLc to non-HDLc and HDLc to TC showed a favorable trend during the intervention period.

As FBs progressed in development, there was a concurrent alleviation of the systemic inflammatory state, indicating a favorable trend ( 40 ).

This indicates a favorable trend toward reduced fertility rates.

Analysis of the variability of results revealed significant step change reductions after incentivization for four indicators (−0.14 to −0.01 CV reductions), and one indicator showed a favorable trend change (−0.03 CV reduction annually; Fig. 2 , Table 2 , Supplementary Figure S5 ).

Additionally, subgroup analysis based on clinical characteristics indicated that the addition of ICIs to the first-line treatment regimen resulted in a favorable trend of OS benefit across the majority of subgroups ( Figure S1 ).

For the post-COVID functional scale (PCFS), the analyses showed a favorable trend in the ordinal scale of this questionnaire.

Therefore, this study indicated a favorable trend for modified-release prednisone when compared with immediate-release prednisone, suggesting that further research is warranted.

The results revealed that compared to docetaxel, enzalutamide sequential therapy (HR: 0.22, 95% CI: 0.03–1.67) and enzalutamide combined therapy (HR: 0.46, 95% CI: 0.06–3.07) exhibited a favorable trend in enhancing the time to PSA progression in mHSPC patients ( Supplementary Material 6R ).

The GeparNUEVO trial used durvalumab plus chemotherapy as neoadjuvant therapy for TNBC and observed an increase in pCR, improvement in invasive disease-free survival (iDFS) and distant disease-free survival (DDFS), and a favorable trend in OS ( 60 ).

However, patients receiving LR showed a favorable trend in 2-year DFS (HR=1.40, 95% CI: 1.16–1.69) and 5-year DFS (HR=1.37; 95% CI: 1.05–1.77), although these results are not conclusive due to underpowered significance.

The combination of two fractions of IR with anti-CTLA4 yielded a favorable trend in tumor growth delay compared to two-fraction IR with IgG, although it was not statistically significant (median days to endpoint: 13.5 Gy × 2 + anti-CTLA4 44 days, 13.5 Gy × 2 + IgG 41.5 days; Figure 4 d).

When limited to the patients with myxoid round cell liposarcoma, the response rate was elevated to 21% (3/14), and the progression-free survival was 7.3 months, showing a favorable trend.

Although adjuvant HAIC (HR: 0.57; 95% CI: 0.31, 1.04) and adjuvant sintilimab (HR: 0.51; 95% CI: 0.25, 1.01) did not reach statistical significance, they still showed a favorable trend.

The results showed a significant reduction in heart failure hospitalization and a favorable trend in reducing cardiovascular death.

Iba et al demonstrated a favorable trend for AT supplement at a dosage of 3000 IU/day over 1500 IU/day for the treatment of sepsis-associated DIC. 13 In the treatment of Septic DIC, it may be necessary to adjust the optimal dose, taking into account not only the difference in source of infection, but also the severity of the patient’s illness and the status of coagulation-fibrinolytic disruption.

The administration of anamorelin as a second-line or earlier treatment resulted in significant appetite improvement and BW gain at 3 weeks, with a favorable trend also observed in appetite improvement and BW gain at 12 weeks.

As can be seen from Table 1 , the mean value of urban green transformation reached 1.046 over the 12-year period, which is greater than unity and represents a favorable trend of green transformation with an average annual growth rate of 4.6 %.